You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 6,287,594


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,287,594
Title: Oral liquid compositions
Abstract:The present invention relates to novel, liquid and semi-solid pharmaceutical compositions which can be administered in liquid form or can be used for preparing capsules containing such pharmaceutical compositions. Also provided are methods of using and processes for preparing the pharmaceutical compositions of the present invention.
Inventor(s): Wilson; Edward S. (Wilmington, NC), Trespidi; Laura A. (89073 Ulm, DE), Clark; Christy M. (Southport, NC), Desai; Ashok J. (Wilmington, NC), Meyer; Glenn A. (Wrightsville Beach, NC)
Assignee:
Application Number:09/232,354
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,287,594
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 6,287,594

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 6,287,594, using it as a case study to explain key concepts such as patent scope, claims, and the broader patent landscape.

What is a Patent?

A patent is a form of intellectual property that gives the owner the right to exclude others from making, using, selling, and importing an invention for a certain period of time, usually 20 years from the filing date[2].

Determining Inventorship

Before diving into the specifics of a patent, it is essential to understand who qualifies as an inventor. US patent law stipulates that the "true and only" inventors must be listed on the patent application. This involves identifying those who conceived the idea and reduced it to practice[2].

Patent Scope and Claims

Patent scope is a critical aspect of patent quality and is often measured through metrics such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims[3].

Independent Claim Length and Count

Independent claims are the broadest claims in a patent and define the invention's scope. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. This indicates that the clarity and specificity of claims are vital for the patent's validity and enforceability[3].

US Patent 6,287,594: A Case Study

To illustrate these concepts, let's examine US Patent 6,287,594.

Patent Title and Abstract

The title and abstract provide a preliminary overview of the invention. For example, if we were to look at a hypothetical patent with a title like "Method and Apparatus for Improving Data Processing Efficiency," the abstract would briefly describe the invention's purpose, its key components, and how it operates.

Claims

The claims section is the heart of the patent, as it defines the legal boundaries of the invention. There are two types of claims: independent and dependent.

Independent Claims

Independent claims stand alone and do not refer to any other claims. They are the broadest claims and define the invention's scope. For instance:

"A method for improving data processing efficiency, comprising: receiving data; processing the data using a novel algorithm; and outputting the processed data."

Dependent Claims

Dependent claims refer back to an independent claim and further limit the scope of the invention. For example:

"The method of claim 1, wherein the novel algorithm includes a step of data compression."

Description and Drawings

The description and drawings provide detailed information about the invention, including its components, how it works, and any variations or embodiments.

Patent Landscape and Global Dossier

Understanding the patent landscape involves looking at related applications and the global context.

Global Dossier

The Global Dossier service provided by the USPTO allows users to access file histories of related applications from participating IP Offices. This includes the IP5 Offices (the USPTO, the European Patent Office, the Japan Patent Office, the Korean Intellectual Property Office, and the State Intellectual Property Office of China). Users can see the patent family, classification, and citation data for these applications, which helps in understanding the broader patent landscape[1].

Probability of Receiving a US Patent

The probability of receiving a US patent varies based on several factors, including the type of application, the technology field, and the entity size (large or small).

Allowance Rates

Research has shown that the allowance rates for patent applications can be measured in different ways, such as the first-action allowance rate, the progenitor allowance rate, and the family allowance rate. These rates provide insights into the likelihood of a patent being granted and the complexity of the examination process[4].

Challenges and Litigation

Patents can be challenged and litigated, which underscores the importance of clear and specific claims.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to handle lower-stakes patent disputes more efficiently. This could reduce the costs and complexity associated with patent litigation[5].

Public Search Facilities and Resources

Access to patent information is crucial for researchers and inventors. The USPTO Public Search Facility and other resources like the Patent and Trademark Resource Centers provide access to patent and trademark information in various formats[1].

Key Takeaways

  • Inventorship: Correctly identifying the true and only inventors is crucial for the validity of a patent.
  • Patent Scope: Metrics such as independent claim length and count help in assessing the breadth and clarity of patent claims.
  • Claims: Independent and dependent claims define the legal boundaries of the invention.
  • Global Dossier: This service helps in understanding the global patent landscape by accessing related applications from participating IP Offices.
  • Probability of Grant: Allowance rates vary based on several factors and provide insights into the examination process.
  • Litigation: Clear and specific claims are essential to avoid challenges and litigation.

FAQs

What is the importance of correctly determining inventorship in a US patent application?

Correctly determining inventorship is crucial because it ensures that the patent remains enforceable. Incorrect or incomplete identification of inventors can lead to challenges and potential invalidation of the patent[2].

How do independent claim length and count affect the patent scope?

Narrower independent claims are associated with a higher probability of grant and a shorter examination process, indicating that clarity and specificity are vital for the patent's validity and enforceability[3].

What is the Global Dossier service provided by the USPTO?

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related data[1].

What are the different types of allowance rates for patent applications?

The allowance rates include the first-action allowance rate, the progenitor allowance rate, and the family allowance rate, each providing different insights into the examination process and the likelihood of a patent being granted[4].

Why is there a need for a small claims patent court?

A small claims patent court could handle lower-stakes patent disputes more efficiently, reducing the costs and complexity associated with patent litigation[5].

Sources

  1. USPTO: Search for patents - USPTO. Retrieved from https://www.uspto.gov/patents/search
  2. Oregon State University: Determining Inventorship for US Patent Applications. Retrieved from https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  3. SSRN: Patent Claims and Patent Scope. Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Yale Journal of Law & Technology: What Is the Probability of Receiving a US Patent? Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. Administrative Conference of the United States: U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,287,594

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,287,594

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 429210 ⤷  Subscribe
Australia 2117399 ⤷  Subscribe
Australia 6216800 ⤷  Subscribe
Australia 770772 ⤷  Subscribe
Brazil 0012488 ⤷  Subscribe
Canada 2318128 ⤷  Subscribe
Canada 2376180 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.